| BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease |
Globe Newswire |
03/30 |
08:00 |
| electroCore Expands Intellectual Property Portfolio |
Globe Newswire |
03/30 |
08:00 |
| Nasdaq Concludes Public Consultation on Nasdaq-100 Index® Methodology |
Globe Newswire |
03/30 |
08:00 |
| JazzCash Onboards Its 1 Millionth Merchant on Pakistan’s National Digital Payments Platform, Advancing the Country’s Cashless Economy |
Globe Newswire |
03/30 |
08:00 |
| Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial |
Globe Newswire |
03/30 |
08:00 |
| JE Cleantech Secures approximately USD$12 million |
Globe Newswire |
03/30 |
08:00 |
| SEALSQ joins ECHONET Consortium as PKI Services provider to Strengthen IoT Security in Smart Home and Energy Networks in Japan |
Globe Newswire |
03/30 |
08:00 |
| Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress |
Globe Newswire |
03/30 |
08:00 |
| Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology |
Globe Newswire |
03/30 |
08:00 |
| Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates |
Globe Newswire |
03/30 |
07:48 |
| Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy |
Globe Newswire |
03/30 |
07:47 |
| MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue |
Globe Newswire |
03/30 |
07:45 |
| WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX |
Globe Newswire |
03/30 |
07:36 |
| FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy |
Globe Newswire |
03/30 |
07:30 |
| BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9 |
Globe Newswire |
03/30 |
07:30 |
| BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder |
Globe Newswire |
03/30 |
07:30 |
| Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate |
Globe Newswire |
03/30 |
07:30 |
| Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026 |
Globe Newswire |
03/30 |
07:20 |
| Appili Therapeutics to Exhibit at World Vaccine Congress Washington |
Globe Newswire |
03/30 |
07:19 |
| Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan |
Globe Newswire |
03/30 |
07:05 |
| Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent |
Globe Newswire |
03/30 |
07:05 |
| PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 |
Globe Newswire |
03/30 |
07:03 |
| Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered |
Globe Newswire |
03/30 |
07:01 |
| Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries |
Globe Newswire |
03/30 |
07:00 |
| Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund |
Globe Newswire |
03/30 |
07:00 |
